Department of Pharmacy, Niigata Cancer Center Hospital, Kawagishi-cho, Chuo-ku, Niigata, Japan.
Pharm Dev Technol. 2012 Nov-Dec;17(6):755-62. doi: 10.3109/10837450.2011.583926. Epub 2011 May 26.
FOLFOX6 and FOLFIRI regimens are often selected as the first- or second-line treatment for advanced or recurrent colorectal cancer. Patients are now able to undergo at-home treatment by using a portable disposable infusion pump (SUREFUSER(®)A) for continuous intravenous infusion of 5-fluorouracil (5-FU). The duration of continuous 5-FU infusion is normally set at an average of 46 h, but large variations in the duration of infusion are observed.
The relationship between the total volume of the drug solution in SUREFUSER(®)A and the duration of infusion was analyzed by regression analysis. In addition, multiple regression analysis of the total volume of the drug solution, dummy variables for temperature, and duration of infusion was carried out.
The duration of infusion was affected by the coefficient of viscosity of the drug solution and the ambient temperature.
The composition of the drug solutions and the ambient temperature must be considered to ensure correct duration of continuous infusion.
FOLFOX6 和 FOLFIRI 方案常被选作晚期或复发性结直肠癌的一线或二线治疗方案。现在,患者可以使用便携式一次性输注泵(SureFuser(®)A)在家中进行持续静脉输注 5-氟尿嘧啶(5-FU)的治疗。持续输注 5-FU 的时间通常设定为平均 46 小时,但输注时间有很大的差异。
通过回归分析,分析了 SureFuser(®)A 中药物溶液的总体积与输注时间之间的关系。此外,还对药物溶液的总体积、温度虚拟变量和输注时间进行了多元回归分析。
输注时间受药物溶液的粘度系数和环境温度的影响。
必须考虑药物溶液的组成和环境温度,以确保持续输注的时间正确。